Sign In  |  Register  |  About Daly City  |  Contact Us

Daly City, CA
September 01, 2020 1:20pm
7-Day Forecast | Traffic

  • Search Hotels in Daly City

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2
...
28 29 30 31 32 33 34 35 36
...
99 100 Next >
ROSEN, A LEADING, LONGSTANDING, AND TOP RANKED FIRM, Encourages bluebird bio Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BLUE
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers BLUE
ROSEN, A LEADING, LONGSTANDING, AND TOP RANKED FIRM, Encourages bluebird bio Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BLUE
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers BLUE
FDA Green Lights Pfizer's Gene Therapy For Rare Bleeding Disorder Hemophilia
Via Benzinga
Exposures Product Safety
Tickers CSLLY PFE
Altria CEO Urges FDA Crackdown On Illicit Vape Products: Report
Via Benzinga
Exposures Product Safety
Tickers HDV MO VTI
Soap Mishap Causes Tesla to Recall Thousands of Cybertrucks
Via Investor Brand Network
Topics Product Recall
Exposures Legal Product Safety
Tickers TSLA
Pfizer Now Rivals The World's Most Expensive Medicine After FDA Approves Gene Therapy
Via Investor's Business Daily
Exposures Product Safety
Tickers PFE QURE
PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) Announces Participation at the 27th Annual Milken Institute Global Conference
Via Investor Brand Network
Exposures Product Safety
Tickers CYBN HLT
Petros Pharmaceuticals announces online distribution for lead ED product with Lemonaid Health
Via News Direct
Exposures Product Safety
Petros Pharmaceuticals announces online distribution for lead ED product with Lemonaid Health
Via TheNewswire.com
Exposures Product Safety
ROSEN, LEADING INVESTOR COUNSEL, Encourages Zoetis Inc. Investors to Inquire About Securities Class Action Investigation - ZTS
Via NewMediaWire
Exposures Product Safety
Tickers ZTS
ROSEN, LEADING INVESTOR COUNSEL, Encourages Zoetis Inc. Investors to Inquire About Securities Class Action Investigation - ZTS
Via TheNewswire.com
Exposures Product Safety
Tickers ZTS
Biogen/Eisai's Popular Alzheimer's Drug Leqembi Is Seeing Slow Adoption - Here's Why
Via Benzinga
Exposures Product Safety
Tickers BIIB ESALY
Best Therapists Carlton North Melbourne Delivers Psychodynamic Psychotherapy - Maple Tree Counselling Announcement
Via Press Advantage
Topics Product Recall
Exposures Legal Product Safety
ANGLE partners with AstraZeneca in groundbreaking oncology contract
Via News Direct
Exposures Product Safety
ANGLE partners with AstraZeneca in groundbreaking oncology contract
Via TheNewswire.com
Exposures Product Safety
Why Is Penny Stock HOOKIPA Pharma Trading Higher On Wednesday?
Via Benzinga
Exposures Product Safety
Tickers GILD HOOK RHHBY
BioMedNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) Completes Key Step in Preparation of PAX-101 for NDA Submission to FDA
Via Investor Brand Network
Exposures Product Safety
Tickers PXMD
AGC Biologics Announces Successful Completion of Production of Cancer-Specific Therapeutic Antibody Fragments with Var2 Pharmaceuticals
Via News Direct
Exposures Product Safety
FDA Approves Novartis' Lutathera As First Therapy For Pediatric Patients With Gastroenteropancreatic Neuroendocrine Tumors
Via Benzinga
Exposures Product Safety
Tickers NVS
What Analysts Are Saying About PepsiCo's Q1 Earnings?
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Tickers GS PEP
Bay Area Start-Up Brings the Power of AI to Breast Cancer Screening
Via PRLog
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Lisata Therapeutics advances lead asset LSTA1 for treatment of advanced solid tumors
Via TheNewswire.com
Exposures Product Safety
This Pharma Co. Kicks Off FDA Approval Process For CBD-Based Treatment Of Chronic Pain
Via Benzinga
Exposures Product Safety
Tickers CSE:INNO INNO INNPF
FDA Approves ImmunityBio's Bladder Cancer Drug, Stock Rallies
Via Benzinga
Exposures Product Safety
Tickers IBRX
FDA Rejects Approval Of Abeona Therapeutics' Skin Disorder Treatment, Shares Sink
Via Benzinga
Exposures Product Safety
Tickers ABEO
Why Is Abeona Therapeutics (ABEO) Stock Down 45% Today?
Via InvestorPlace
Exposures Product Safety
Tickers ABEO HWH PEGY
Mayo Clinic Diet Survey Spotlights Important Correlation Between Weight Loss Medication and Behavioral Support Programs
Via PRUnderground
Exposures Product Safety
ROSEN, A LEADING NATIONAL FIRM, Encourages bluebird bio Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BLUE
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers BLUE
ROSEN, A LEADING NATIONAL FIRM, Encourages bluebird bio Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BLUE
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers BLUE
420 with CNW — FDA Boss Says DEA Doesn’t Have Reason to Delay Cannabis Rescheduling
Via Investor Brand Network
Topics Cannabis
Exposures Cannabis Product Safety
< Previous 1 2
...
28 29 30 31 32 33 34 35 36
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 DalyCity.com & California Media Partners, LLC. All rights reserved.